Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Stomach Cancer
- Targeted Therapy
- Head and Neck Oncology
- Immunotherapy
- Carcinomas
- Urological Cancers
- Haemato-Oncology
- Bladder Cancer
August-2019
Impact of Dexamethasone on Metabolic Profile and Survival in Glioblastoma
Yislenz Narváez-Martínez, Carme Balaña , Maria Buxó , Gemma Mateu , Alfredo Gimeno , Gerard Blasco , Josep Puig , Carme Joly-Torta , Marina Castellví-Juan , Jose Luis CaroCardera , Alejandro Ortega , Carlos Cohn and Sonia del Barco
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2019;4(1):1654.DOI: 10.25107/2474-1663.1654
Jejunal Adenocarcinoma on Celiac Disease
Sabbah M1*, Trad D1 , Jouini R2, Bellil N1, Haddad D3, Ouakaa A1 and Gargouri D1
Abstract PDF Full Text Clinical Image | Open Access
Citation: Clin Oncol. 2019;4(1):1653.DOI: 10.25107/2474-1663.1653
Biphasic Pulmonary Blastoma - A Rare Lung Tumor: Case Report
Calado T1 *, Antunes M1 , Cabral D1 , Pereira C2 , Alves P2 and Félix F1
Abstract PDF Full Text Case Report | Open Access
Citation: Clin Oncol. 2019;4(1):1652.DOI: 10.25107/2474-1663.1652
Seven Metachronous Primary Cancers within 27 Years in a Woman
Ming-Ho Wu* and Han-Yun Wu
Abstract PDF Full Text Case Report | Open Access
Citation: Clin Oncol. 2019;4(1):1651.DOI: 10.25107/2474-1663.1651
Enteric Type - Adenocarcinoma of the Prostate Associated with Atypical Intestinal Metaplasia of the Prostate: Report of First Case and Review of Literature
Ahmed Shabaik1 *, Michael Hahn2 and John Paul Shen3
Abstract PDF Full Text Case Report | Open Access
Citation: Clin Oncol. 2019;4(1):1650.DOI: 10.25107/2474-1663.1650
Abdominal Aura as a Presentation of Cavernous Hemangioma
María Inguanzo-Ortiz*
Abstract PDF Full Text Clinical Image | Open Access
Citation: Clin Oncol. 2019;4(1):1649.DOI: 10.25107/2474-1663.1649
A Huge Mediastinal Liposarcoma and Its Recurrence
Ming-Ho Wu* and Han-Yun Wu
Abstract PDF Full Text Clinical Image | Open Access
Citation: Clin Oncol. 2019;4(1):1648.DOI: 10.25107/2474-1663.1648
Does Statistical Decrease of Mortality Rates by a Factor of about 2.5 Suggest Revolutional Progress in Melanoma Treatment from Year 2009 to 2017?
Ernst-Peter Rührnschopf*
Abstract PDF Full Text Short Communication | Open Access
Citation: Clin Oncol. 2019;4(1):1647.DOI: 10.25107/2474-1663.1647
Bevacizumab and PEGylated Liposomal Doxorubicin in the Treatment of Relapsed Osteosarcoma
Asleh M, Abu Quider A, Ben-Harosh M, Fruchtman Y, Beck G and Kapelushnik J*
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2019;4(1):1646.DOI: 10.25107/2474-1663.1646
Detection of Tumor-Related Biomarkers in Hepatocellular Carcinoma Patients by Sequencing Circulating Cell-Free DNA
Hao Wang1 , Huabang Zhou1 , Xiaoyan Li1 , Peng Wang1 , Guofang Liu1 , Wendi Liu1 , Liping Lei1 , Nan He2 and Heping Hu1 *
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2019;4(1):1645.DOI: 10.25107/2474-1663.1645
The Interplay of Proteins Encoded by CDKN1A, CDKN1B, CDKN2A and TP53 in the Prognosis of Breast Cancer
Valentina Robila1 *, Bryce S Hatfield1 , Nitai Mukhopadhyay2 and Michael O Idowu1
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2019;4(1):1644.DOI: 10.25107/2474-1663.1644
